United States · FDA National Drug Code directory

TriStart DHA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
15370-250_4889480e-2d59-4dbd-a808-ea7fce24f922
Product NDC
15370-250
Form
CAPSULE, LIQUID FILLED
Composition / generic term
ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE MAGNESIUM, FOLIC ACID, CYANOCOBALAMIN, IRON PENTACARBONYL, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT, and ICOSAPENT
Labeler
CarWin Pharmaceutical Associates, LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start / end (source format)
20150601
Source listing expiry
20261231

Source-listed ingredients

  • ASCORBIC ACID — 55 mg/1
  • CHOLECALCIFEROL — 1000 [iU]/1
  • .ALPHA.-TOCOPHEROL ACETATE, D- — 15 [iU]/1
  • THIAMINE HYDROCHLORIDE — 1.3 mg/1
  • RIBOFLAVIN — 1.8 mg/1
  • NIACIN — 5 mg/1
  • PYRIDOXINE HYDROCHLORIDE — 35 mg/1
  • LEVOMEFOLATE MAGNESIUM — 600 ug/1
  • FOLIC ACID — 400 ug/1
  • CYANOCOBALAMIN — 14 ug/1
  • IRON PENTACARBONYL — 31 mg/1
  • POTASSIUM IODIDE — 200 ug/1
  • MAGNESIUM OXIDE — 30 mg/1
  • DOCONEXENT — 200 mg/1
  • ICOSAPENT — 15 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (15370-250-30) · 15370-250-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →